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Single use technologies require a close collaboration between supplier and end-user with regards to cleanliness
issues, primarily focused on particulate contamination. Since a large percentage of drug recalls relate to
particulate contamination, and detection of a single visible particle in a dose of injectable drug is considered a
critical issue and thus causes significant time and money to remedy, reduction of risk related to particulate
contamination is of highest priority. Particulate detection is challenging in single use systems due to the
complexity of the devices. As this presentation will show, concerted efforts to reduce particulate generation at all
steps of the manufacturing process by using quality by design and risk reduction principles can bring large
benefits.
This presentation will detail the method used jointly by two suppliers along the manufacturing supply chain for
vial stoppers and syringe plungers to improve quality and to decrease the risk of particle contamination in
injectable drug products. The stoppering of a vial or prefilled syringe is a critical process step during the
manufacturing of drug products since particulates remaining on the stopper or plunger could potentially end up
in the product and lead to a product recall. Therefore it is necessary for the stopper supplier to have process
capabilities with regards to particle contamination under control. Control starts from the design phase for the
stopper, where it is critical to follow quality by design principles. An adequate cleanroom environment and good
manufacturing practices drive the final cleanliness of the product, and it is critical to have a continuous
improvement program in place. A process fish bone analysis and FMEA is the approach chosen for this case
study in order to identify the risk of contamination and in parallel to improve the stopper manufacturing process
including the final packaging. Thus, particulate reduction methods were applied all along the supply chain in a
successful effort to reduce particulate contamination risk.

